G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.
In the next five years, the GACR of GPCR Tools is about 3.6%, and the revenue in the 2022 is about 1760 M USD. GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 40% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein.
The classification of GPCR Tools includes GPCR Consumables and GPCR Equipment, and the proportion of GPCR Consumables in 2016 is about 70% and the proportion is increasing trend from 2012 to 2016.
In terms of therapeutic areas, the market has been segmented into: Oncology, cardiovascular system, central nervous system (CNS), etc. Oncology was the largest segment of the global GPCRs market in 2016 and the proportion in 2016 is 50%.
North America is the largest consumption place, with a consumption market share nearly 49% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30.4%.
Market competition is intense. Thermo Fisher Scientific, PerkinElmer, Merck, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry.
The global G-Protein Coupled Receptor (GPCR) Targeting market is valued at 83 million US$ in 2020 is expected to reach 99.9 million US$ by the end of 2026, growing at a CAGR of 2.6% during 2021-2026.
This report focuses on G-Protein Coupled Receptor (GPCR) Targeting volume and value at the global level, regional level and company level. From a global perspective, this report represents overall G-Protein Coupled Receptor (GPCR) Targeting market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the G-Protein Coupled Receptor (GPCR) Targeting market is segmented into
GPCR Consumables
GPCR Equipment
Segment by Application
Oncology
Cardiovascular System
Central Nervous System
Other
Global G-Protein Coupled Receptor (GPCR) Targeting Market: Regional Analysis
The G-Protein Coupled Receptor (GPCR) Targeting market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the G-Protein Coupled Receptor (GPCR) Targeting market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global G-Protein Coupled Receptor (GPCR) Targeting Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global G-Protein Coupled Receptor (GPCR) Targeting market include:
Thermo Fisher Scientific
PerkinElmer
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Cisbio
Discoverx
Enzo Life Sciences
In the next five years, the GACR of GPCR Tools is about 3.6%, and the revenue in the 2022 is about 1760 M USD. GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 40% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein.
The classification of GPCR Tools includes GPCR Consumables and GPCR Equipment, and the proportion of GPCR Consumables in 2016 is about 70% and the proportion is increasing trend from 2012 to 2016.
In terms of therapeutic areas, the market has been segmented into: Oncology, cardiovascular system, central nervous system (CNS), etc. Oncology was the largest segment of the global GPCRs market in 2016 and the proportion in 2016 is 50%.
North America is the largest consumption place, with a consumption market share nearly 49% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30.4%.
Market competition is intense. Thermo Fisher Scientific, PerkinElmer, Merck, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry.
The global G-Protein Coupled Receptor (GPCR) Targeting market is valued at 83 million US$ in 2020 is expected to reach 99.9 million US$ by the end of 2026, growing at a CAGR of 2.6% during 2021-2026.
This report focuses on G-Protein Coupled Receptor (GPCR) Targeting volume and value at the global level, regional level and company level. From a global perspective, this report represents overall G-Protein Coupled Receptor (GPCR) Targeting market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the G-Protein Coupled Receptor (GPCR) Targeting market is segmented into
GPCR Consumables
GPCR Equipment
Segment by Application
Oncology
Cardiovascular System
Central Nervous System
Other
Global G-Protein Coupled Receptor (GPCR) Targeting Market: Regional Analysis
The G-Protein Coupled Receptor (GPCR) Targeting market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the G-Protein Coupled Receptor (GPCR) Targeting market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global G-Protein Coupled Receptor (GPCR) Targeting Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global G-Protein Coupled Receptor (GPCR) Targeting market include:
Thermo Fisher Scientific
PerkinElmer
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Cisbio
Discoverx
Enzo Life Sciences
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.